Nuvo Pharmaceuticals, Inc.

Nuvo Pharmaceuticals, Inc. is a pharmaceutical company focused on the development, commercialization, and marketing of innovative branded pharmaceuticals and healthcare products targeting specialty markets. Founded in 1983 and headquartered in Mississauga, Canada, Nuvo Pharmaceuticals, Inc. specializes in pharmaceuticals and healthcare products.

The company's most recent funding round was an ADD-ON round in December 2022, where they raised CAD 15. 4 million led by Searchlight Pharma Inc. The deal involved Searchlight Pharma acquiring Nuvo Pharmaceuticals, which has allowed for the addition of a proven team and a portfolio of brands. The company, now a part of Searchlight Pharma, has expanded its operations into Montreal, Toronto, and Dublin.

Nuvo Pharmaceuticals offers a portfolio that includes over 65 brands focused on key therapeutic areas such as women’s health, dermatology, allergy, neurology, and pain management. Their products are tailored to address specific healthcare challenges, ensuring effective treatment options for patients. The company's customer base comprises healthcare providers, institutions, pharmacies, and patients, primarily in Canada and select international markets, supported by strategic partnerships that enhance product access. Nuvo Pharmaceuticals generates revenue through the commercialization of its pharmaceutical products and strategic partnerships.

They conduct B2B transactions, distributing their products to healthcare institutions, pharmacies, and direct consumers. Revenue is generated through direct sales of their flagship products, with a commitment to building their portfolio through partnerships that expand distribution capabilities while adhering to regulatory requirements in the pharmaceutical sector. Following the acquisition by Searchlight Pharma Inc. in December 2022, Nuvo Pharmaceuticals is poised for growth by onboarding a proficient team and expanding its brand portfolio into new therapeutic areas.

The funding will be utilized to support this expansion, which includes the establishment of offices in Montreal, Toronto, and Dublin. The company is actively designing and launching new products aimed at addressing unmet healthcare needs, thereby positioning itself for entry into additional markets.